Veteran Executive Frederick M. Lowery Takes Helm as Henry Schein CEO
Henry Schein, Inc. — one of the world’s largest providers of dental and medical supplies — has announced the appointment of Frederick M. Lowery as its new Chief Executive Officer, effective March 2, 2026. Lowery succeeds Stanley M. Bergman, who is stepping down after a historic 35-year tenure leading the company and will continue serving as Chairman of the Board to ensure a seamless transition.
Lowery brings more than two decades of healthcare leadership and operational expertise, most recently serving as Executive Vice President and President of Laboratory Products and BioProduction at Thermo Fisher Scientific, where he led global distribution performance and business expansion. His appointment aligns with Henry Schein’s strategy to accelerate growth, operational excellence, and customer impact across its global healthcare channels.
A New Era for a Fortune 500 Healthcare Leader
Under Lowery’s leadership, Henry Schein aims to build on its historic legacy — transforming from a regional distributor into a global healthcare solutions powerhouse now serving millions of dental and medical professionals worldwide. With deep experience in distribution, product strategy, and value-added services, Lowery is positioned to drive innovation alongside Henry Schein’s BOLD+1 strategic plan, emphasizing higher-margin specialties, technology, and global scale.
Bergman praised the choice of Lowery, highlighting his operational expertise and leadership philosophy that resonates with Henry Schein’s values and mission to support clinicians and patients. The strategic partnership with investment firm KKR — which made a significant investment in 2025 — further reinforces the company’s growth trajectory under new leadership.
